Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  liposomal cytarabine-daunorubicin CPX-351
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
CPX-351 in Treating Patients with Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 60 and over
Trial IDs: HEM0036, NCI-2013-01982, 28524, NCT02019069
CPX-351 in Treating Patients with Newly Diagnosed, High-Risk Acute Myeloid Leukemia
Phase: Phase II
Type: Treatment
Age: Over 18
Trial IDs: 2014-0548, NCI-2014-02529, NCT02286726
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients with Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 2642.00, NCI-2013-00481, 2642, NCT01804101
Start Over